This includes lysine acetylation and lysine ubiquitination, both of which have been linked to neurodegeneration in AD (21, 22, 23) and O-GlcNAc modification of serine and threonine, which was reported to prevent phosphorylation and aggregation of Tau (24, 25). Here, MAPT is linked to Alzheimer disease.